Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.33 |
| ▸ | PEPD | P12955 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4272527 | 0.91 | BTN3A1 (0.37) | BTN3A1 | |
| SCHEMBL1369448 | 0.79 | TYMS (0.42) | BTN3A1 | |
| SCHEMBL632959 | 0.79 | PEPD (0.34) | PEPD | |
| SCHEMBL1557153 | 0.79 | BTN3A1 (0.37) | BTN3A1 | |
| Methacrylic Acid SCHEMBL2639351 | 0.76 | THRB (0.47) | BTN3A1PEPDTHRB | |
| Methacrylic Acid SCHEMBL491387 | 0.74 | BLM (0.39) | THRB | |
| Diethylamine SCHEMBL6858469 | 0.73 | SAT1 (0.31) | — | |
| Methacrylic Acid SCHEMBL21049927 | 0.72 | LPAR3 (0.43) | — | |
| SCHEMBL1557385 | 0.72 | GABBR2 (0.35) | BTN3A1 | |
| SCHEMBL5604146 | 0.72 | BTN3A1 (0.32) | BTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4791042-B2 | — | — | 2011-10-12 | — | — | JP | claimed |
| EP-1401562-B1 | PROCESS FOR THE FORMATION OF EMULSIONS | SYNGENTA LTD (GB) | 2008-10-08 | — | — | EP | claimed |
| US-7199185-B2 | Use of reactive polymeric surfactants in the formation of emulsions | SYNGENTA LIMITED (GB) | 2007-04-03 | — | — | US | claimed |
| EP-1569512-B1 | PARTICULATE SUSPENSIONS | SYNGENTA LTD (GB) | 2007-02-28 | — | — | EP | claimed |
| US-20060116290-A1 | Particulate suspensions | SYNGENTA CROP PROTECTION, INC. | 2006-06-01 | — | — | US | claimed |
| EP-1569512-A2 | PARTICULATE SUSPENSIONS | Syngenta Limited (GB) | 2005-09-07 | — | — | EP | claimed |
| US-20040197357-A1 | Use of reactive polymeric surfactants in the formation of emulsions | SYNGENTA LIMITED (GB) | 2004-10-07 | — | — | US | claimed |
| WO-2004052099-A2 | PARTICULATE SUSPENSIONS | SYNGENTA LIMITED (GB) | 2004-06-24 | — | — | WO | claimed |
| EP-1401562-A2 | USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS | Syngenta Limited (GB) | 2004-03-31 | — | — | EP | claimed |
| WO-2002100525-A2 | USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS | SYNGENTA LIMITED (GB) | 2002-12-19 | — | — | WO | claimed |
| EP-1401562-B1 | PROCESS FOR THE FORMATION OF EMULSIONS | SYNGENTA LTD (GB) | 2008-10-08 | — | — | EP | disclosed |
| US-7199185-B2 | Use of reactive polymeric surfactants in the formation of emulsions | SYNGENTA LIMITED (GB) | 2007-04-03 | — | — | US | disclosed |
| EP-1569512-B1 | PARTICULATE SUSPENSIONS | SYNGENTA LTD (GB) | 2007-02-28 | — | — | EP | disclosed |
| US-20060116290-A1 | Particulate suspensions | SYNGENTA CROP PROTECTION, INC. | 2006-06-01 | — | — | US | disclosed |
| EP-1569512-A2 | PARTICULATE SUSPENSIONS | Syngenta Limited (GB) | 2005-09-07 | — | — | EP | disclosed |
| US-20040197357-A1 | Use of reactive polymeric surfactants in the formation of emulsions | SYNGENTA LIMITED (GB) | 2004-10-07 | — | — | US | disclosed |
| WO-2004052099-A2 | PARTICULATE SUSPENSIONS | SYNGENTA LIMITED (GB) | 2004-06-24 | — | — | WO | disclosed |
| EP-1401562-A2 | USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS | Syngenta Limited (GB) | 2004-03-31 | — | — | EP | disclosed |
| WO-2002100525-A2 | USE OF REACTIVE POLYMERIC SURFACTANTS IN THE FORMATION OF EMULSIONS | SYNGENTA LIMITED (GB) | 2002-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197357-A1 | Use of reactive polymeric surfactants in the formation of emulsions | PHOSPHO1, APOB, LIPA | BTN3A1 2256/4885PEPD 3476/4885THRB 2972/4885 |
| US-20060116290-A1 | Particulate suspensions | PFAS, VCL, JMJD7 | BTN3A1 3199/4885PEPD 962/4885THRB 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.